Cancer Research UK logo.
SearchDonate
  • Search

A trial of cabozantinib after chemotherapy for sarcoma of the womb that has spread or can’t be removed with an operation (HGUtS study)

Overview

Cancer types:

Sarcoma, Soft tissue sarcoma, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women with rare types of high grade sarcoma of the womb.

Cancer Research UK supports this trial.

Recruitment start: 23 February 2016

Recruitment end: 30 June 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Helen Hatcher

Supported by

Cancer Research UK

Exelixis

Experimental Cancer Medicine Centre (ECMC)

European Organisation for Research and Treatment of Cancer (EORTC)

International Rare Cancer Initiative (IRCI)

NHS Greater Glasgow and Clyde

Other information

This is Cancer Research UK trial number CRUK/13/020.

Last reviewed: 25 Nov 2025

CRUK internal database number: 11734

Help and support